Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

2010 Annual Meeting | Myelopathies

Sunday 04/11/10
02:15 PM - 06:00 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
PM Half-Day Course
Neeraj Kumar, MD
Participants should be able to confidently diagnose the wide spectrum of disorders of the spinal cord and have a practical approach toward the work up and management of these patients; be aware of the recent advances in conditions like neuromyelitis optica, copper deficiency myelopathy, hereditary spastic paraplegia, myelopathies related to spinal dural arteriovenous fistulas, and paraneoplastic myelopathies; and know the recommendations regarding use of steroids in compressive myelopathies.
No CME available
Patient Care & Procedural Skills, Medical Knowledge
Trainee, General Neurologist, Specialist Neurologist
Case-based, Didactic, Audience Participation
Event Timeline
02:15 PM - 03:00 PM Spinal Cord Syndromes and Vascular Myelopathies
Jose Biller, MD, FACP, FAHA, FÂ鶹´«Ã½Ó³»­
03:00 PM - 03:45 PM Inflammatory and Infectious Myelopathies
Dean M. Wingerchuk, MD, FÂ鶹´«Ã½Ó³»­
03:45 PM - 04:00 PM Break
04:00 PM - 04:45 PM Metabolic and Hereditary Myelopathies
Neeraj Kumar, MD
04:45 PM - 05:30 PM Neoplastic and Other Compressive Myelopathies
Julie E. Hammack, MD, FÂ鶹´«Ã½Ó³»­
05:30 PM - 06:00 PM Panel Discussion, Interesting Cases, Questions and Answers
Faculty Disclosures
Neeraj Kumar, MD Dr. Kumar has nothing to disclose.
Dean M. Wingerchuk, MD, FÂ鶹´«Ã½Ó³»­ Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Meyer Squibb. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwers.
Jose Biller, MD, FACP, FAHA, FÂ鶹´«Ã½Ó³»­ Dr. Biller has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwer. Dr. Biller has received publishing royalties from a publication relating to health care.
Julie E. Hammack, MD, FÂ鶹´«Ã½Ó³»­ Dr. Hammack has nothing to disclose.